Patent · US Active

Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate

US7714020B2 · kind B2 · utility

13Cited by

39References

19Claims

0Family size

Assignee

Neuren Pharmaceuticals Limited · NL

Inventors

Peter Gluckman · Auckland, NZ
Margaret Anne Brimble · Hamilton, NZ
Douglas C. Wilson · Taupō, NZ
Frank C. Tortella · Columbia, US
Anthony Williams · Middletown, US
Xi-Chun May Lu · Laurel, US
Jed A. Hartings · Silver Spring, US
Divina Gryder · McLean, US

Key dates

Filing date	Apr 4, 2006
Grant date	May 11, 2010
Priority date	—
Expiry date	Aug 24, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Aspects of this invention include the use of G-2MePE to treat patients with brain injury characterized by non-convulsive seizures. G-2MePE is useful in treating brain injuries caused by traumatic brain injury, stroke, hypoxia/ischemia and toxic injury.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.